Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKooth Plc Regulatory News (KOO)

Share Price Information for Kooth Plc (KOO)

Share Price is delayed by 15 minutes
Get Live Data
162.50    -5.50 (-3.27%)
Bid:
160.00
Ask:
165.00
Spread: 5.00 (3.125%)
Market Cap: £58.94m
KOO Live PriceLast checked at - London Stock Exchange

Intraday Kooth Plc Share Chart

Trading Statement

22 Jan 2024 07:00

RNS Number : 3608A
Kooth PLC
22 January 2024
 

22 January 2024

 

Kooth plc

("Kooth" or the "Group")

Trading Update

 

Kooth, a global leader in youth digital mental well-being, announces a trading update for the financial year ended 31 December 2023.

 

2023 revenues are expected to be approximately £33.3 million, a year-on-year increase of c.65%. This strong growth excludes c.$4 million of revenue billed in 2023 relating to revenues received from US contracts, which had been expected to be recognised in 2023, but will now be paid and recognised in early 2024.

 

The Group has a robust balance sheet and positive operating cashflow. As at 31 December 2023 the Group had an unaudited net cash balance of £10.9 million (2022: £8.5m), and has recently entered into a working capital credit facility with Citibank of $9.5 million that remains undrawn at this time.

 

Kooth successfully launched its digital mental health platform and mobile app, Soluna, in California in January 2024 and is finalising discussions with the State of Pennsylvania regarding an extension of its current service contract, which began as a pilot programme in October 2022.

 

For the UK market we saw revenue growth for 2023, but as previously reported, we expect headwinds to remain in the near term, reflecting a focus on NHS cost saving and the ongoing acute care backlog. We remain focused on demonstrating the impact and savings that Kooth generates when commissioned in a region.

 

We will provide a further update on progress at the Group's Full Year Results which are expected to be announced in March 2024.

 

Tim Barker, Chief Executive Officer of Kooth, said:

"2023 was a year of significant progress for Kooth, underlined by our largest contract win with the State of California. Alongside our work in Pennsylvania, Kooth is now a leader in the important US digital mental health market and a provider of choice for the provision of services to children and young people. This momentum, combined with our strong financial performance and our ability to generate recurring revenue, leaves us well placed for further progress in 2024. The need for digital mental health services is as great as ever and we look forward to ensuring that Kooth remains a trusted and growing provider for children and young people both in the US and UK."

 

-Ends-

Enquiries:

 

Kooth plc

investorrelations@kooth.com

 Tim Barker, CEO

 Sanjay Jawa, CFO

 Stifel, Nominated Adviser & Sole Broker

+44 (0) 20 7710 7600

 Ben Maddison, Nick Adams, Erik Anderson, Nicholas Harland

 FTI Consulting

kooth@fticonsulting.com

 Jamie Ricketts, Alex Shaw, Usama Ali, Kirstie-Anne Woodman

 

 

About Kooth plc:

 

Kooth (AIM:KOO) is a global leader in youth digital mental well-being. Our mission is to provide accessible and safe spaces for everyone to achieve better mental health. Our platform is clinically robust and accredited to provide a range of therapeutic support and interventions. All our services are predicated on easy access to make early intervention and prevention a reality.

Kooth is a fully safeguarded and pre-moderated community with a library of peer and professional created content, alongside access to experienced online counsellors. There are no thresholds for support and no waiting lists.

Kooth is the longest standing digital mental health provider to hold a UK-wide accreditation from the British Association of Counselling and Psychotherapy (BACP) and according to NHS England data for 2022/23 is now the largest single access provider for mental health support for under 18s.

In 2021, Kooth began executing on its international expansion strategy, with an initial focus on the US market. This focus is due to the growing recognition of the importance of improving youth mental health in this key global healthcare market, with 1-in-6 people aged 6-17 experiencing a mental health disorder each year.

 

Notes

1. As outlined on 4 July 2023, the company expected revenues for the year ending December 2023 to be not less than £34m.

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBRGDBBUBDGSC
Date   Source Headline
24th Jan 20257:00 amRNSTransaction in Own Shares
23rd Jan 20257:02 amRNSTransaction in Own Shares
23rd Jan 20257:00 amRNSTrading update, Board changes & succession plans
22nd Jan 20257:00 amRNSTransaction in Own Shares
21st Jan 20257:00 amRNSTransaction in Own Shares
20th Jan 20257:00 amRNSTransaction in Own Shares
17th Jan 20257:00 amRNSTransaction in Own Shares
16th Jan 20257:00 amRNSTransaction in Own Shares
15th Jan 20257:00 amRNSTransaction in Own Shares
14th Jan 20257:00 amRNSTransaction in Own Shares
13th Jan 20257:00 amRNSTransaction in Own Shares
10th Jan 20257:00 amRNSTransaction in Own Shares
8th Jan 20257:00 amRNSTransaction in Own Shares
6th Jan 20257:00 amRNSTransaction in Own Shares
3rd Jan 20257:00 amRNSTransaction in Own Shares
2nd Jan 20257:00 amRNSTransaction in Own Shares
31st Dec 20247:00 amRNSTransaction in Own Shares
24th Dec 20247:01 amRNSShare Buyback Programme
24th Dec 20247:00 amRNSUS pilot contract win
16th Dec 20242:04 pmRNSHoldings in Company
27th Nov 202410:49 amRNSHoldings in Company
26th Nov 20245:12 pmRNSHoldings in Company
26th Nov 202410:17 amRNSHoldings in Company
30th Oct 202411:31 amRNSDirector Trading
28th Oct 20242:49 pmRNSHoldings in Company
25th Oct 20247:00 amRNSStatement regarding share price movement
18th Oct 202411:27 amRNSUpdate on Pennsylvania pilot contract
8th Oct 20246:03 pmRNSHolding in Company
8th Oct 20247:00 amRNSResult of Secondary Placing in Kooth Plc
7th Oct 20244:35 pmRNSProposed Secondary Placing in Kooth Plc
17th Sep 20247:00 amRNSHalf Year Results
10th Sep 202410:24 amRNSNotice of Half Year Results
30th Aug 20247:00 amRNSKooth Block Listing Six Monthly Return
20th Aug 20247:00 amRNSKooth launches service partnership with Aetna
14th Aug 20245:54 pmRNSTR-1: Standard form
25th Jul 20247:00 amRNSKooth Half Year Trading Update
18th Jun 202411:20 amRNSResult of 2024 AGM
24th May 20247:00 amRNS2023 Annual Report and Notice of AGM
30th Apr 20247:00 amRNSDirectorate Change
23rd Apr 20247:00 amRNSInvestor Presentation via Investor Meet Company
26th Mar 20247:00 amRNSAnnual Financial Report
1st Mar 20247:00 amRNSBlock Listing Six Monthly Return
22nd Jan 20247:00 amRNSTrading Statement
9th Jan 20247:00 amRNSLaunch of California contract
14th Nov 202311:41 amRNSHolding(s) in Company
27th Oct 202310:19 amRNSAwards under Incentive Plan & PDMR dealing
16th Oct 20235:27 pmRNSHolding(s) in Company
16th Oct 20233:06 pmRNSHolding(s) in Company
11th Oct 202311:24 amRNSHolding(s) in Company
5th Oct 20236:25 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.